GIM
MXCT icon

Granahan Investment Management’s MaxCyte MXCT Stock Holding History

Granahan Investment Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,428,449
Closed -$6.71M – 192
2023
Q4 		$6.71M Sell
1,428,449
-547,398
-28% -$2.13M 0.22% 115
2023
Q3 		$6.16M Buy
1,975,847
+83,959
+4% +$338K 0.22% 116
2023
Q2 		$8.68M Buy
1,891,888
+1,183,731
+167% +$5.44M 0.27% 100
2023
Q1 		$3.51M Buy
708,157
+31,867
+5% +$157K 0.11% 141
2022
Q4 		$3.69M Buy
676,290
+578,089
+589% +$3.54M 0.11% 144
2022
Q3 		$638K Buy
+98,201
New +$548K 0.02% 170

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Granahan Investment Management's MXCT Position: Q1 2024 in Review

Granahan Investment Management sold out of MaxCyte (MXCT) in Q1 2024, closing a stake of 1,428,449 shares — an estimated $6.71M sold.

Granahan Investment Management first reported a position in MXCT in Q3 2022 and held it in 6 quarters. The position peaked at $8.68M in Q2 2023. 123 funds tracked by Wall St. Rank hold MXCT as of Q1 2024.

  • Granahan Investment Management reported no remaining MaxCyte position as of Q1 2024 after selling out during the quarter.
  • Granahan Investment Management sold 1,428,449 MaxCyte shares in Q1 2024, an estimated $6.71M.
  • Granahan Investment Management first reported a position in MaxCyte in Q3 2022 and held it in 6 quarters.
  • Granahan Investment Management's MaxCyte position peaked at $8.68M in Q2 2023.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q1 2024.

Based on Granahan Investment Management's 13F filing for Q1 2024, filed 15 May 2024.